World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
42989
World Ranking
6243
National Ranking
3332

Overview

Michael H. Baumann is affiliated with the National Institute on Drug Abuse in the United States. Their research focuses on areas within neuroscience and medicine, producing a significant body of work in the fields of cellular and molecular neuroscience, molecular biology, toxicology, clinical psychology, and pharmacology.

The main topics covered in Michael H. Baumann's research include:

  • Neurotransmitter Receptor Influence on Behavior
  • Forensic Toxicology and Drug Analysis
  • Psychedelics and Drug Studies
  • Pharmacological Receptor Mechanisms and Effects
  • Cannabis and Cannabinoid Research
  • Neuroscience and Neuropharmacology Research
  • Chemical synthesis and alkaloids

Some of the frequent publication venues where their work has appeared are:

  • Journal of Pharmacology and Experimental Therapeutics
  • Psychopharmacology
  • Neuropharmacology
  • ACS Chemical Neuroscience
  • The FASEB Journal

Their recent papers include:

  • "Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs," 2020, International Journal of Drug Policy
  • "Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice," 2022, ACS Pharmacology & Translational Science
  • "Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid," 2022, Archives of Toxicology
  • "U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market," 2020, Brain Sciences
  • "First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass," 2022, Archives of Toxicology

Michael H. Baumann has collaborated frequently with a number of coauthors, including:

  • Grant C. Glatfelter
  • Donna Walther
  • Christophe P. Stove
  • David R. Manke
  • A.R. Chadeayne

Best Publications

  • Expanding global access to radiotherapy

    Rifat Atun;David A Jaffray;David A Jaffray;David A Jaffray;Michael B Barton;Freddie Bray

  • Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

    Richard B. Rothman;Michael H. Baumann;Christina M. Dersch;Dana V. Romero

  • Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines

    Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet

  • Exploring the role of cancer stem cells in radioresistance.

    Michael Baumann;Mechthild Krause;Richard Hill

  • Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

    Richard B. Rothman;Michael H. Baumann;Jason E. Savage;Laura Rauser

  • Radiation oncology in the era of precision medicine

    Michael Baumann;Mechthild Krause;Jens Overgaard;Juergen Debus

  • Monoamine transporters and psychostimulant drugs.

    Richard B. Rothman;Michael H. Baumann

  • The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

    Michael H Baumann;Mario A Ayestas;John S Partilla;Jacqueline R Sink

  • Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

    Michael H Baumann;John S Partilla;Kurt R Lehner;Eric B Thorndike

  • Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

    William A. Carlezon;Cécile Béguin;Jennifer A. DiNieri;Michael H. Baumann

  • Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial

    Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann

  • Caring for patients with cancer in the COVID-19 era.

    Joris van de Haar;Louisa R. Hoes;Charlotte E. Coles;Kenneth Seamon

  • Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments.

    Mechthild Krause;Anna Dubrovska;Annett Linge;Michael Baumann

  • Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer

    Daniel Zips;Klaus Zöphel;Nasreddin Abolmaali;Rosalind Perrin

  • 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

    Michael H. Baumann;Xiaoying Wang;Richard B. Rothman

  • Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.

    Mahmoud Toulany;Ulla Kasten-Pisula;Ingo Brammer;Shaomeng Wang

  • Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

    Audrey Mauguen;Cécile Le Péchoux;Michele I. Saunders;Steven E. Schild

  • First clinical application of a prompt gamma based in vivo proton range verification system

    Christian Richter;Guntram Pausch;Guntram Pausch;Steffen Barczyk;Steffen Barczyk;Marlen Priegnitz

  • N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

    Michael H Baumann;Robert D Clark;Allison G Budzynski;John S Partilla

  • Misuse of Novel Synthetic Opioids: A Deadly New Trend.

    Matthew P. Prekupec;Peter A. Mansky;Michael H. Baumann

Frequent Co-Authors

Richard B. Rothman
Richard B. Rothman National Institute on Drug Abuse
Kenner C. Rice
Kenner C. Rice National Institutes of Health
Claus Belka
Claus Belka Ludwig-Maximilians-Universität München
Richard A. Glennon
Richard A. Glennon Virginia Commonwealth University
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center
Harald H. Sitte
Harald H. Sitte Medical University of Vienna
Marilyn A. Huestis
Marilyn A. Huestis National Institute on Drug Abuse
Jean Lud Cadet
Jean Lud Cadet National Institute on Drug Abuse
Frank Buchholz
Frank Buchholz TU Dresden
Yavin Shaham
Yavin Shaham National Institute on Drug Abuse

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in exploring alternative healthcare careers or pathways that complement your study of Medicine in the USA? There are a growing number of online degree options that can prepare you for key roles in the healthcare sector — all from the flexibility of home.

For those seeking advanced pharmacy careers, pharmd online programs offer a rigorous, accredited route to becoming a practicing pharmacist. If your interests lie in managing healthcare data, a health information technology online degree can open doors in health informatics and administration.

You can also enter the health workforce quickly through affordable medical billing and coding programs, which are ideal for those looking for practical skills in medical office operations and digital records. Aspiring nurses might consider cheap online fnp programs to advance toward a high-demand nurse practitioner role.

These online programs provide greater accessibility, often at a lower cost, and can lead to rewarding career opportunities within the broader healthcare landscape.

Best Scientists Citing Michael H. Baumann

Trending Scientists

Recently Published Articles